Lipolytic, Energy Expenditure, and Insulinotropic Eﬀects of HM12525A, A Novel Long-Acting GLP-1 Glucagon Dual Agonist 116-LB YJ Park1, SY Jung1, *, JK Kim1, JS Lee1, YM Lee1, YH Kim1, JH Kang1, M Trautmann2, M Hompesc - YJ - Document - PDFSEARCH.IO

First Page	Meta Content
	Lipolytic, Energy Expenditure, and Insulinotropic Eﬀects of HM12525A, A Novel Long-Acting GLP-1/Glucagon Dual Agonist 116-LB YJ Park1, SY Jung1, *, JK Kim1, JS Lee1, YM Lee1, YH Kim1, JH Kang1, M Trautmann2, M Hompesc Add to Reading List Document Date: 2014-08-11 00:02:42 Open Document File Size: 2,16 MB Share Result on Facebook City San Francisco / Seoul / / Company Hanmi Pharm / SC Kwon1 Pharm / / Country South Korea / United States / / Currency pence / / / Facility 2Proﬁl Institute / / IndustryTerm food intake / food / energy / / MedicalCondition SAD / / Organization American Diabetes Association / 2Proﬁl Institute / / / Position mediator / / Product Glucagon / Epinephrine / / SocialTag Anti-diabetic drugs Medicine Biology Eli Lilly and Company Pancreatic hormones Liraglutide Glucagon-like peptide-1 Glucagon Anti-diabetic medication Endocrine system

Lipolytic, Energy Expenditure, and Insulinotropic Eﬀects of HM12525A, A Novel Long-Acting GLP-1/Glucagon Dual Agonist 116-LB YJ Park1, SY Jung1, *, JK Kim1, JS Lee1, YM Lee1, YH Kim1, JH Kang1, M Trautmann2, M HompescAdd to Reading List